Michihide Mitsumori1, Masahiro Hiraoka
1Dept. of Therapeutic Radiology and Oncology, Kyoto University Hospital.
Boost irradiation after breast conserving therapy may be overtreatment for Japanese patients with negative margins. However, its benefit for patients under 40 warrants further investigation in Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: